6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Addiction : Nursing
- Substance Abuse Nursing
People with chronic drug use may show side effects influencing the focal sensory system. Multidisciplinary treatment groups may offer the most refreshed treatment and care. Pharmacotherapy is one standard treatment, powerful in overseeing maniacal manifestations with steady psychosocial intercessions. The proof of chronic drug use has advanced severally. Lifetime use rates seem to have expanded, and early abatement from illicit drug use problems is currently normal. Supported medication free abatement is all around archived, in spite of the fact that rates are still low. Exploration on illicit drug use is prompting information in numerous zones, including attributes of chronic drug use, purposes behind people with chronic drug use looking for substances, impacts of various substances upon manifestations, and obstructions to sedate use recuperation.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States